Global Fish Skin Disease 麻豆原创 Research Report 2025

Publication ID:

PB504259377

Publication Date:

May 2, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Fish Skin Disease was valued at US$ 1960 million in the year 2024 and is projected to reach a revised size of US$ 3147 million by 2031, growing at a CAGR of 7.1% during the forecast period.
North American market for Fish Skin Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Fish Skin Disease is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Fish Skin Disease in Aquaculture Producers is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Fish Skin Disease include Zoetis Inc., Elanco Animal Health, Norvartis, MSD Animal Health, Benchmark Holdings, Phibro Animal Health Corporation, Intervet Inc., Merck Animal Health, Novartis AG, Pharmaq AS, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fish Skin Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fish Skin Disease.
The Fish Skin Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fish Skin Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fish Skin Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Zoetis Inc.
Elanco Animal Health
Norvartis
MSD Animal Health
Benchmark Holdings
Phibro Animal Health Corporation
Intervet Inc.
Merck Animal Health
Novartis AG
Pharmaq AS
AquaBounty Technologies
Alltech
Nutreco
Biomin
Skretting
Segment by Type
Antibiotics
Vaccines
Probiotics
Phage Therapy
Other Natural Treatments
Segment by Application
Aquaculture Producers
Fisheries
Other organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fish Skin Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Fish Skin Disease 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibiotics
1.2.3 Vaccines
1.2.4 Probiotics
1.2.5 Phage Therapy
1.2.6 Other Natural Treatments
1.3 麻豆原创 by Application
1.3.1 Global Fish Skin Disease 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Aquaculture Producers
1.3.3 Fisheries
1.3.4 Other organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fish Skin Disease 麻豆原创 Perspective (2020-2031)
2.2 Global Fish Skin Disease Growth Trends by Region
2.2.1 Global Fish Skin Disease 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Fish Skin Disease Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Fish Skin Disease Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Fish Skin Disease 麻豆原创 Dynamics
2.3.1 Fish Skin Disease Industry Trends
2.3.2 Fish Skin Disease 麻豆原创 Drivers
2.3.3 Fish Skin Disease 麻豆原创 Challenges
2.3.4 Fish Skin Disease 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fish Skin Disease Players by Revenue
3.1.1 Global Top Fish Skin Disease Players by Revenue (2020-2025)
3.1.2 Global Fish Skin Disease Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Fish Skin Disease 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Fish Skin Disease Revenue
3.4 Global Fish Skin Disease 麻豆原创 Concentration Ratio
3.4.1 Global Fish Skin Disease 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fish Skin Disease Revenue in 2024
3.5 Global Key Players of Fish Skin Disease Head office and Area Served
3.6 Global Key Players of Fish Skin Disease, Product and Application
3.7 Global Key Players of Fish Skin Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Fish Skin Disease Breakdown Data by Type
4.1 Global Fish Skin Disease Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Fish Skin Disease Forecasted 麻豆原创 Size by Type (2026-2031)
5 Fish Skin Disease Breakdown Data by Application
5.1 Global Fish Skin Disease Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Fish Skin Disease Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Fish Skin Disease 麻豆原创 Size (2020-2031)
6.2 North America Fish Skin Disease 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Fish Skin Disease 麻豆原创 Size by Country (2020-2025)
6.4 North America Fish Skin Disease 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fish Skin Disease 麻豆原创 Size (2020-2031)
7.2 Europe Fish Skin Disease 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Fish Skin Disease 麻豆原创 Size by Country (2020-2025)
7.4 Europe Fish Skin Disease 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fish Skin Disease 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Fish Skin Disease 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Fish Skin Disease 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Fish Skin Disease 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fish Skin Disease 麻豆原创 Size (2020-2031)
9.2 Latin America Fish Skin Disease 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Fish Skin Disease 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Fish Skin Disease 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fish Skin Disease 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Fish Skin Disease 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Fish Skin Disease 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Fish Skin Disease 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis Inc.
11.1.1 Zoetis Inc. Company Details
11.1.2 Zoetis Inc. Business Overview
11.1.3 Zoetis Inc. Fish Skin Disease Introduction
11.1.4 Zoetis Inc. Revenue in Fish Skin Disease Business (2020-2025)
11.1.5 Zoetis Inc. Recent Development
11.2 Elanco Animal Health
11.2.1 Elanco Animal Health Company Details
11.2.2 Elanco Animal Health Business Overview
11.2.3 Elanco Animal Health Fish Skin Disease Introduction
11.2.4 Elanco Animal Health Revenue in Fish Skin Disease Business (2020-2025)
11.2.5 Elanco Animal Health Recent Development
11.3 Norvartis
11.3.1 Norvartis Company Details
11.3.2 Norvartis Business Overview
11.3.3 Norvartis Fish Skin Disease Introduction
11.3.4 Norvartis Revenue in Fish Skin Disease Business (2020-2025)
11.3.5 Norvartis Recent Development
11.4 MSD Animal Health
11.4.1 MSD Animal Health Company Details
11.4.2 MSD Animal Health Business Overview
11.4.3 MSD Animal Health Fish Skin Disease Introduction
11.4.4 MSD Animal Health Revenue in Fish Skin Disease Business (2020-2025)
11.4.5 MSD Animal Health Recent Development
11.5 Benchmark Holdings
11.5.1 Benchmark Holdings Company Details
11.5.2 Benchmark Holdings Business Overview
11.5.3 Benchmark Holdings Fish Skin Disease Introduction
11.5.4 Benchmark Holdings Revenue in Fish Skin Disease Business (2020-2025)
11.5.5 Benchmark Holdings Recent Development
11.6 Phibro Animal Health Corporation
11.6.1 Phibro Animal Health Corporation Company Details
11.6.2 Phibro Animal Health Corporation Business Overview
11.6.3 Phibro Animal Health Corporation Fish Skin Disease Introduction
11.6.4 Phibro Animal Health Corporation Revenue in Fish Skin Disease Business (2020-2025)
11.6.5 Phibro Animal Health Corporation Recent Development
11.7 Intervet Inc.
11.7.1 Intervet Inc. Company Details
11.7.2 Intervet Inc. Business Overview
11.7.3 Intervet Inc. Fish Skin Disease Introduction
11.7.4 Intervet Inc. Revenue in Fish Skin Disease Business (2020-2025)
11.7.5 Intervet Inc. Recent Development
11.8 Merck Animal Health
11.8.1 Merck Animal Health Company Details
11.8.2 Merck Animal Health Business Overview
11.8.3 Merck Animal Health Fish Skin Disease Introduction
11.8.4 Merck Animal Health Revenue in Fish Skin Disease Business (2020-2025)
11.8.5 Merck Animal Health Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Fish Skin Disease Introduction
11.9.4 Novartis AG Revenue in Fish Skin Disease Business (2020-2025)
11.9.5 Novartis AG Recent Development
11.10 Pharmaq AS
11.10.1 Pharmaq AS Company Details
11.10.2 Pharmaq AS Business Overview
11.10.3 Pharmaq AS Fish Skin Disease Introduction
11.10.4 Pharmaq AS Revenue in Fish Skin Disease Business (2020-2025)
11.10.5 Pharmaq AS Recent Development
11.11 AquaBounty Technologies
11.11.1 AquaBounty Technologies Company Details
11.11.2 AquaBounty Technologies Business Overview
11.11.3 AquaBounty Technologies Fish Skin Disease Introduction
11.11.4 AquaBounty Technologies Revenue in Fish Skin Disease Business (2020-2025)
11.11.5 AquaBounty Technologies Recent Development
11.12 Alltech
11.12.1 Alltech Company Details
11.12.2 Alltech Business Overview
11.12.3 Alltech Fish Skin Disease Introduction
11.12.4 Alltech Revenue in Fish Skin Disease Business (2020-2025)
11.12.5 Alltech Recent Development
11.13 Nutreco
11.13.1 Nutreco Company Details
11.13.2 Nutreco Business Overview
11.13.3 Nutreco Fish Skin Disease Introduction
11.13.4 Nutreco Revenue in Fish Skin Disease Business (2020-2025)
11.13.5 Nutreco Recent Development
11.14 Biomin
11.14.1 Biomin Company Details
11.14.2 Biomin Business Overview
11.14.3 Biomin Fish Skin Disease Introduction
11.14.4 Biomin Revenue in Fish Skin Disease Business (2020-2025)
11.14.5 Biomin Recent Development
11.15 Skretting
11.15.1 Skretting Company Details
11.15.2 Skretting Business Overview
11.15.3 Skretting Fish Skin Disease Introduction
11.15.4 Skretting Revenue in Fish Skin Disease Business (2020-2025)
11.15.5 Skretting Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Zoetis Inc.
Elanco Animal Health
Norvartis
MSD Animal Health
Benchmark Holdings
Phibro Animal Health Corporation
Intervet Inc.
Merck Animal Health
Novartis AG
Pharmaq AS
AquaBounty Technologies
Alltech
Nutreco
Biomin
Skretting

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.